Disclosures for "KITE-363: An Autologous Anti-CD19/CD20 CAR-T Product for the Treatment of Neuroinflammatory Autoimmune Diseases"
-
Ms. Lowe has received personal compensation for serving as an employee of Kite, a Gilead Company. Ms. Lowe has or had stock in Kite, a Gilead Company.
-
Ms. Kim has nothing to disclose.
-
Mr. Flores has nothing to disclose.
-
Mr. Margaitis has received personal compensation for serving as an employee of Kite Pharma. Mr. Margaitis has stock in Kite Pharma.
-
Mr. Calo has received personal compensation for serving as an employee of Gilead Sciences, Inc. Mr. Calo has stock in Gilead Sciences, Inc.
-
Ms. Konecny has received personal compensation for serving as an employee of Kite Pharma.
-
Mrs. Jaghatspanyan has nothing to disclose.
-
Mr. Yoder has received personal compensation for serving as an employee of Kite, A Gilead Company. Mr. Yoder has stock in Kite, a Gilead Company.
-
Dr. Ertel has received personal compensation for serving as an employee of Kite Pharma. Dr. Ertel has stock in Gilead.
-
Dr. Filosto has received personal compensation for serving as an employee of Kite, a Gilead Company. Dr. Filosto has stock in Gilead Sciences.
-
Dr. Murakami has stock in Gilead. Dr. Murakami has stock in Allogene. Dr. Murakami has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Barrett has received personal compensation for serving as an employee of Gilead. Dr. Barrett has stock in Gilead.